Health restrictions on transgender adults and children; weight-loss companies to include obesity drugs; hormone patches or creams for menopause may have lower blood pressure risk than pills
Transgender Adults in Florida Shocked by New Gender-affirming Law
Florida's new law signed by Governor Ron DeSantis (R) has not only restricted gender-affirming care for transgender children but has also made it difficult for many transgender adults to access treatment, according to The Associated Press. Transgender adults in Florida felt blindsided when they discovered that the law would limit their access to health care. The law imposes strict regulations, including the requirement of an informed consent form and in-person visits with a physician, while allowing doctors and pharmacists to refuse treatment for transgender individuals.
Weight-loss Companies Shift Business Strategies to Include Obesity Drugs
Due to increased demand, WeightWatchers and Noom are adapting their business models to include prescription medications like Wegovy and Ozempic, according to NBC News. The companies report they are responding to an evolving understanding of obesity as a chronic disease and customer requests for medication options. By offering access to these drugs, they aim to provide more comprehensive solutions for weight loss, acknowledging the limitations of traditional diet and exercise approaches.
Hormone Patches or Creams for Menopause Symptoms Linked to Lower Blood Pressure Risk Compared to Pills
New research indicates that women who use hormone therapy to alleviate menopause symptoms may have a lower risk of high blood pressure if they opt for patches or creams instead of pills, according to ABC News. The study found that those who took estrogen pills had a 14% higher risk of developing hypertension compared to those who used skin patches or creams. While further research is needed to fully understand the relationship between hormone therapy and blood pressure, the findings highlight the importance of monitoring blood pressure in women using oral hormone therapy.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More